-
Souped-up VPNs play 'cat and mouse' game with Iran censors
-
Attacked Russian tanker drifting toward Libya: Italian authorities
-
Coroner 'not satisfied' boxer Hatton intended to take own life
-
Stocks drop, as oil rises as Mideast war persists
-
Vanishing glacier on Germany's highest peak prompts ski lift demolition
-
Chuck Norris, roundhouse-kicking action star, dead at 86: family
-
Supreme leader says Iran dealt enemies 'dizzying blow'
-
Arsenal must 'attack trophy' in League Cup final, says Arteta
-
Audi team principal Wheatley in shock exit after two races
-
Spurs boss Tudor hopes for 'nice surprises' in relegation fight
-
Arsenal must prove they are winners in League Cup final, says Arteta
-
Record-breaking heat wave grips western US
-
Liverpool showdown brings back 'beautiful memories' for PSG coach Luis Enrique
-
IRA bomb victims drop civil court claim against Gerry Adams
-
Ntamack returns for Toulouse to face France rival Jalibert
-
Trump calls NATO allies 'cowards' over Iran
-
French jihadist jailed for life for Islamic State crimes against Yazidis
-
Chuck Norris, action man who inspired endless memes, dead at 86: family
-
Action movie star Chuck Norris has died: family statement
-
England stars have 'last chance' to earn World Cup spots: Tuchel
-
League Cup final a 'big moment' for Man City, says Guardiola
-
Injured Ronaldo misses Portugal World Cup friendlies
-
Liverpool condemn 'cowardly' racist abuse of Konate
-
Far from war, global fuel frustrations mount
-
German auto exports to China plunged a third in 2025: study
-
Coach Valverde to leave Bilbao at end of season
-
'Decimated'? The Iranian leaders killed in Israeli-US war
-
Mistral chief calls for European AI levy to pay creatives
-
Liverpool suffer Salah blow in chase for Champions League
-
Mahuchikh soars to world indoor high jump gold, Hodgkinson cruises
-
Spain include Joan Garcia as one of four new call-ups
-
Stocks dip, oil calmer as Mideast war persists
-
Salah ruled out of Liverpool's Brighton clash
-
Ship crews ration food in Iran blockade: seafarers
-
Kuwait refinery hit as Iran marks New Year under shadow of war
-
England recall Mainoo, Maguire for pre-World Cup matches
-
Jerusalem's Muslims despair as war shuts Al-Aqsa Mosque for Eid
-
'War has aged us': Lebanon's kids aren't alright
-
Snooker great O'Sullivan makes history with highest-ever break
-
Kuwait refinery hit as Iran says missile production 'no concern'
-
Crude down as Netanyahu looks to reassure on war
-
India to tackle global obesity with cheap fat-loss jabs
-
Somaliland centre saves cheetahs from trafficking to Gulf palaces
-
China swim sensation Yu, 13, beats multiple Olympic medallist
-
North Korean leader, daughter try out new tank
-
Israel strikes 'decimated' Iran as war roils markets
-
James ties NBA record for most regular-season games in latest milestone
-
Trump's Mideast muddle could play into Xi's hands at planned summit
-
New BTS album drops ahead of comeback mega-gig
-
Australia must be 'smart' to beat Japan in Asian Cup final: coach
Ozempic Meals? Restaurants shrink portions to match bite-sized hunger
A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city's famed restaurant culture.
Then she started Ozempic.
She lost her appetite -- "my desire for cocktails and desserts and anything sweet" -- and also more than 20 pounds (9.1 kilograms) in less than two months.
But "I still wanted to maintain my social lifestyle, and I still wanted to be included in dinners," the Swedish 41-year-old who works in the tequila industry told AFP.
One of her favorite restaurants, Manhattan's Le Petit Village, made that easier: it's among the dining establishments in the city offering smaller portions at lower prices, as the prevalence of medications that reduce hunger like Ozempic grows.
The West Village restaurant decided to shrink a corner of its brunch menu, including French toast and a smoked salmon tartine, not least to accommodate diners on GLP-1s who want to go out but can't eat much.
Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are increasingly popular for weight loss, according to a November poll by the non-profit health policy tracker KFF.
And one in five say they've taken the medications whose brand names include Ozempic and Wegovy -- which are also prescribed to manage chronic conditions like diabetes -- at some point.
On Monday, Danish pharmaceutical giant Novo Nordisk announced US authorities had approved Wegovy to be administered in pill form for weight loss, potentially making it even more accessible.
Some in the restaurant industry are taking note.
"I was going out and seeing people eat a lot less and take one bite of their food and one sip of their drink and that was it," said Aristotle Hatzigeorgiou, who owns Clinton Hall, which has five locations across New York.
And on top of that, much of the dishes his kitchens prepared ended up in the trash -- "a mass amount of waste," he said.
So he developed the "teeny-weeny mini meal" -- for $8, diners get a bite-sized burger, a small portion of fries and their choice of a 3-oz beer, martini or glass of wine.
It's a stark contrast to some of the beer hall's other offerings, which include a "doughnut grilled cheese" and a "fondue burger" (they are what they sound like.)
But the mini-meal has proven a hit, Hatzigeorgiou said, not only for those dropping weight but for those cutting costs.
"I think people are definitely strapped with rents going up and inflation," said the restaurant owner.
Offering "a cheaper option to come out," he said, has "been working."
- 'Vast human experiment' -
For now, GLP-1s for weight loss purposes remain too expensive for many Americans.
But experts expect that will shift; even US President Donald Trump has promised affordable options.
And researchers are starting to examine how wider GLP-1 use is shaking cultural connections to food.
"Food is your enemy, instead of your great pleasure in life? I mean, that's very different," Marion Nestle, a professor emerita of nutrition at New York University, told AFP in an interview. "I think the jury is out on all of it."
Side effects of GLP-1s can include unpleasant gastrointestinal issues, but for some people, Nestle said, the medications have proven "miraculous."
The nutritionist said it's far too soon to have a grasp on long-term impact, physiologically or socioculturally: "It's a vast human experiment."
Axmacher told AFP she's taken Ozempic on and off.
When she first decided to take a break, "I was ready to feel like I could enjoy life a little bit more again."
"I do enjoy the sense of hunger and satisfaction when I get to eat something I'm in the mood for," she said, adding that on Ozempic, "I missed that."
But using the medication also helped her develop positive and sustainable habits, she said: Axmacher cut down on alcohol, exercised more, and focused on eating enough protein.
Ozempic or not, a trend of smaller restaurant dishes in the wake of America's 1990s-2000s Super Size Era can only be positive, Nestle said.
Le Petit Village management told AFP they're considering expanding their menu of half-sized portions to dinner service, and Clinton Hall is working on developing a mini-meal featuring chicken.
Some customers, Hatzigeorgiou said, have noted that "this is what meals used to look like."
"We think it's something different, but maybe it's not so different," he said with a chuckle. "Maybe it's the right-sized meal."
V.Said--SF-PST